Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

Status unconfirmed · Phase 4

Conditions studied: Degenerative Osteoarthritis

In brief

This study is being done to investigate the colonization rate(growth rate) of a particular type of low-virulence (does not typically cause infection) bacterium called Propionibacterium, more specifically P acnes, the same bacterium that is responsible for the majority of acne. Information affecting hip surgery is currently unknown.

Key facts

Study ID

NCT03849885

Run by

Colorado Joint Replacement

People needed

496

Starts

2019-02-02

Expected to finish

2024-12-31

Last updated by the study team

2023-01-10

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients who are 18 to 79 85 years of age
• CJR primary joint arthroplasty patients who are receiving care at Porter Adventist Hospital
• CJR established primary knee or hip arthroplasty patients with a native hip joint (no replacement on the biopsy side) who volunteers as a research participant.
• CJR patients without a previous arthroplasty procedure who have established care with our practice.

You may not qualify if…

• Previous history of hip infection
• Current antibiotic use or antibiotic use within the past week
• Previous history of Cutibacterium joint infection
• Current immunodeficiency disease or disorder
• Patients with active psoriatic disease or other focal inflammation over the hip
• Previous total hip arthroplasty (bilateral for the case of TKA patients and healthy volunteers, contralateral for THA patients)

Where it is running

• Colorado Joint Replacement — Denver, Colorado, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.